SKF-97426

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameSKF-97426
Drug Alias NameSKF-97426SKF-97426A
ClassificationSmall molecules
Mechanisms of ActionBile acid binding protein modulators
TargetsBile acid binding protein
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A